# Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

> **NCT02652975** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 76 (actual)

## Conditions studied

- Breast Neoplasms
- Endothelial Dysfunction
- Cardiovascular Disease
- Metabolic Syndrome

## Interventions

- **PROCEDURE:** Venous occlusion plethysmography
- **PROCEDURE:** SphygmoCor
- **PROCEDURE:** 24hour blood pressure
- **PROCEDURE:** DEXA scan
- **BIOLOGICAL:** Laboratory blood samples

## Key facts

- **NCT ID:** NCT02652975
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2019-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652975, "Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02652975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*